P90520 AF NFT

DNA topoisomerase 2, mitochondrial

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeig3xdvv52mwbm7lyhr4nk2borvlx42zn6zg4bunm2y4npgsxzixy4/metadata.json
IPFS of structure file: 
bafybeihihwlc67qub4bcmhm2cmfuwayulei2s4ag5tah6zcbrkveli3m4a/AF-P90520-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xbCDc8dCF5740f40DccC5eb23D421a373B3e1f998
First NFT owner address (bech32): 
genesis1hnwgmn6hgr6qmnx9av3aggdrwwe7r7vc9v7nun
Current NFT ID #470021 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
470021
Accession (UniProt):
P90520
Name::
DNA topoisomerase 2, mitochondrial
Experimental Method:
Predicted structure
Sequence source:
DICTYOSTELIUM DISCOIDEUM

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT P90520 research and analysis (ICN3D with VR)

FASTA sequences

>sp|P90520|TOP2M_DICDI DNA topoisomerase 2, mitochondrial OS=Dictyostelium discoideum OX=44689 GN=top2mt PE=2 SV=2 MSKLLNNNNHKNLTNYLKFGKGIINNLNNKSKQVGIISFISQSSIQSQSSIQSQSFLSINNNSNNKYFSTKLNKNEKISEKTTTRKIEDIYQKKTPTEHVLLRPDSYIGTIEKIEDDMWVLSNSMFNKEKKTIELNNDNNEKNVESTTTTTTKTNKKPLTYIHPIKATYIPGLLKIYDEILVNAADNKKRDSKMSFIKVEINPNENSISIMNDGKGIPVVMHQTENCYVVEMVMGNLMSGSNFNDSELKVVGGRNGFGAKLTNIFSKEFTVETVDKSSGKKYFQRWSNNMGDRSEPIITPIGEGESDYTKITFKPDLEKFKIKSLWDDNILQLMERRLYDIAGCNTELMVTLNGKRLNYNFQSYVKLYEHHLNNSTKREDNEEQYREESFEFGEISPRWKIGIGLSETGQFTQVSFVNSINTVKGGTHVNFLADQIVRYVGEKLKKKHSDLEIRPMNIKHHLALFVNCLVDNPSFDSQSKETLTTKPMLFGSTPEIPESLLAQFVKNSKIIERVAGWALMKQKADLIHSTSGRQSKTTLIKSISKLDDANWAGGLKSKECTLIITEGDSAKSLALAGLSVVGRNSYGVFPLRGKLLNVRDVASKQLLSNEEINNLTTILGLSHKNSYDTDESMEDLRYGRVMIMADQDHDGSHIKGLVMNFIHYFWPNLLKRGFLVEFVTPIIKATKSSTQKKSFFTIKDYEKWRETISSDQLKQYTIKYYKGLGTSTSAEAKEYFSNLDKHVIKFIWGDEADDLIKMAFAKDLSSLRQRWIKETDMSQGIDHSIKEITYPDFINKELIHYSWAANLRSIPSLIDGLKPGQRKILFASFKRRLTNEIKVSQLSGYVAEQTSYHHGEQSLNSTIVKMAHNFVGSNNLPLLTPSGQFGTRLQGGSDSASARYIFTKLEPVARYLFNELDDPLLNYLEEEGESIQPDYYIPIIPMLLVNGSEGIGVGMSTSIPLFSPIDIIDQLMLRLNNQVALKKLIPWYRGFKGTISPDRHTYRTNGVIKLVGRNLEITELPIGRWTSDYKEVLNDLIDKDVIKSFQESNTENSVHFTILLNNNQLEQMEDLTENELIKLFKLSASLNFHLTCFDENSKIQKLESVEEIIDQFYKVRLQFYGKRREYLLKSLDNQIKRLTTTIQFLEVIASGKLKIQGRSKQDLIKELESGEIVGFENFGTHPPEVYQHLFSLSILDITKERIDNLTNQLTKRKSEHQSISSSDPKSLWTADLQQLKEYLEKSDKEFQKKPLKTSSSSSFDVSSSSESAKLSSTRKSKTDKIKSK